Aureus Asset Management, LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 922 filers reported holding NOVARTIS A G in Q2 2017. The put-call ratio across all filers is 0.64 and the average weighting 0.5%.

Quarter-by-quarter ownership
Aureus Asset Management, LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q4 2020$342,000
+8.9%
3,619
+0.1%
0.03%
-3.3%
Q3 2020$314,000
-7.4%
3,615
-6.9%
0.03%
-18.9%
Q2 2020$339,000
+8.7%
3,884
+2.7%
0.04%
-14.0%
Q1 2020$312,000
-15.4%
3,781
-2.9%
0.04%
+4.9%
Q4 2019$369,000
+10.8%
3,894
+1.5%
0.04%0.0%
Q3 2019$333,000
-11.9%
3,835
-7.3%
0.04%
-12.8%
Q2 2019$378,000
-2.1%
4,135
+3.0%
0.05%
-7.8%
Q1 2019$386,000
+12.2%
4,016
+0.1%
0.05%
-5.6%
Q4 2018$344,000
-9.2%
4,011
-8.9%
0.05%
+12.5%
Q3 2018$379,000
-4.3%
4,402
-15.9%
0.05%
-11.1%
Q2 2018$396,000
-4.8%
5,237
+1.8%
0.05%
-12.9%
Q1 2018$416,000
+1.7%
5,146
+5.5%
0.06%
-1.6%
Q4 2017$409,000
-1.2%
4,876
+1.0%
0.06%
-3.1%
Q3 2017$414,000
-2.4%
4,826
-5.1%
0.06%
-8.5%
Q2 2017$424,000
+6.0%
5,0850.0%0.07%
+2.9%
Q1 2017$400,000
+36.5%
5,085
+26.5%
0.07%
+21.1%
Q4 2016$293,000
+1.7%
4,020
+10.2%
0.06%
-1.7%
Q3 2016$288,000
+34.0%
3,649
+40.3%
0.06%
+26.1%
Q2 2016$215,000
-12.6%
2,600
-9.2%
0.05%
-16.4%
Q4 2015$246,000
-39.6%
2,862
-35.3%
0.06%
-45.5%
Q3 2015$407,000
-4.2%
4,426
+2.3%
0.10%
+13.5%
Q2 2015$425,000
+86.4%
4,326
+87.1%
0.09%
+71.2%
Q1 2015$228,0002,3120.05%
Other shareholders
NOVARTIS A G shareholders Q2 2017
NameSharesValueWeighting ↓
Martin Investment Management, LLC 229,184$23,344,6827.00%
Foresight Global Investors, Inc. 97,500$9,397,7375.23%
SCHARF INVESTMENTS, LLC 1,425,745$145,226,3224.34%
MANAGED ASSET PORTFOLIOS, LLC 274,204$27,930,3694.28%
GARLAND CAPITAL MANAGEMENT INC 54,710$5,572,7613.93%
PRENTISS SMITH & CO INC 52,032$5,299,9803.91%
WILKINS INVESTMENT COUNSEL INC 130,950$13,3393.61%
First Fiduciary Investment Counsel, Inc. 145,731$14,8443.48%
Cullen Capital Management, LLC 2,714,809$276,530,4643.23%
JOHN G ULLMAN & ASSOCIATES INC 182,690$18,608,8033.04%
View complete list of NOVARTIS A G shareholders